The investigators compared the perioperative, oncological, functional and immunological outcomes of endoscopic submucosal dissection against laparoscopic assisted gastrectomy for treatment of early gastric cancer. With virtually no abdominal incisions and minimal pain induced, endoscopic submucosal dissection is expected to be less invasive when compared to laparoscopic assisted gastrectomy for treatment of early gastric cancer. This study will show that endoscopic submucosal dissection is associated with a significantly better perioperative recovery and less immunological disturbance. Moreover, it will also induce a better long term outcomes as the stomach can be preserved, hence the digestive function is maintained to prevent long term functional morbidities of the gastrointestinal tract. This study will be the unique first study in the literature to show that intramucosal early gastric cancer can be adequately treated by endoscopic submucosal dissection with better perioperative, functional and quality of life outcomes when compared to laparoscopic assisted gastrectomy.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
36
Combined Endoscopy Center, Prince of Wales Hospital
Hong Kong, Hong Kong
Complication
Time frame: 30 days after procedure
Postop VAS score on pain measurement
Measured by VAS pain score daily until the day of discharge by dedicated independent assessor Daily measurement until the day of discharge the type and dose of analgesic requirement is also documented
Time frame: 30 days
Hospital stay
The number of days that patient stayed in hospital
Time frame: through study completion, an average of 1 year
Time (hours) for Operative
The Time measured by hours from start of operation after general anesthesia until end of the operation
Time frame: Up to 24 hours
Quality of life assessment by SF36
As measured by SF 36
Time frame: From date of operation on every followup appointment until 24 months after operation
Mortality
Time frame: 30 days after procedure
Overall Survival
Time frame: up to 5 years after operation
Recurrence
Time frame: up to 5 years after operation
Disease free survival
Time frame: up to 5 years after operation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.